Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate

Brief summary (registry, in English)

The COMFORT study will evaluate an artificial intelligence-based platform developed to support the clinical assessment of kidney and prostate cancer. The platform utilises imaging data to provide AI-generated outputs intended to assist clinicians in the assessment of suspected lesions. The primary objective of the study is to assess the role of the COMFORT platform in the clinical decision making process of clinicians managing kidney or prostate cancer cases. Secondary objectives include evaluation of the performance of AI models on anatomical segmentations, tumor characterisation (localisation, volumetric measurements, lesion classification, and scoring (e.g., Bosniak, PI-RADS, RENAL). Also the acceptability, usability, utility and trustworthiness of the AI models will be evaluated. In addition, potential causes of privacy leakage associated with the COMFORT AI models will be evaluated as part of the platform's privacy assessment.

What you commit to

• Study type: Observational
• Planned participants: 50
• From 15 Oct 2026 to the primary completion date, 31 Dec 2026
• 6 sites in 4 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.